Dergi makalesi Açık Erişim

Evaluation of potential tumor markers that may predict neoadjuvant treatment efficiency in rectal cancer

Arslan, Fatma Demet; Kocak, Ayse; Aydin, Cengiz; Pala, Emel Ebru; Oncel, Dilek; Diniz, Gulden; Kaya, Tayfun; Ugurlu, Levent; Degirmenci, Mustafa; Ozkan, Bulent; Soysal, Yasemin; Said, Harun Muayad


MARC21 XML

<?xml version='1.0' encoding='UTF-8'?>
<record xmlns="http://www.loc.gov/MARC21/slim">
  <leader>00000nam##2200000uu#4500</leader>
  <datafield tag="700" ind1=" " ind2=" ">
    <subfield code="a">Kocak, Ayse</subfield>
    <subfield code="u">Dokuz Eylul Univ, Inst Hlth Sci, Dept Mol Med, Izmir, Turkey</subfield>
  </datafield>
  <datafield tag="700" ind1=" " ind2=" ">
    <subfield code="a">Aydin, Cengiz</subfield>
    <subfield code="u">Univ Hlth Sci, Tepecik Training &amp; Res Hosp, Gen Surg Clin, Izmir, Turkey</subfield>
  </datafield>
  <datafield tag="700" ind1=" " ind2=" ">
    <subfield code="a">Pala, Emel Ebru</subfield>
    <subfield code="u">Univ Hlth Sci, Tepecik Training &amp; Res Hosp, Med Pathol Clin, Izmir, Turkey</subfield>
  </datafield>
  <datafield tag="700" ind1=" " ind2=" ">
    <subfield code="a">Oncel, Dilek</subfield>
    <subfield code="u">Univ Hlth Sci, Tepecik Training &amp; Res Hosp, Radiol Clin, Izmir, Turkey</subfield>
  </datafield>
  <datafield tag="700" ind1=" " ind2=" ">
    <subfield code="a">Diniz, Gulden</subfield>
    <subfield code="u">Univ Hlth Sci, Tepecik Training &amp; Res Hosp, Med Pathol Clin, Izmir, Turkey</subfield>
  </datafield>
  <datafield tag="700" ind1=" " ind2=" ">
    <subfield code="a">Kaya, Tayfun</subfield>
    <subfield code="u">Univ Hlth Sci, Tepecik Training &amp; Res Hosp, Med Pathol Clin, Izmir, Turkey</subfield>
  </datafield>
  <datafield tag="700" ind1=" " ind2=" ">
    <subfield code="a">Ugurlu, Levent</subfield>
    <subfield code="u">Univ Hlth Sci, Tepecik Training &amp; Res Hosp, Med Pathol Clin, Izmir, Turkey</subfield>
  </datafield>
  <datafield tag="700" ind1=" " ind2=" ">
    <subfield code="a">Degirmenci, Mustafa</subfield>
    <subfield code="u">Univ Hlth Sci, Tepecik Training &amp; Res Hosp, Oncol Clin, Izmir, Turkey</subfield>
  </datafield>
  <datafield tag="700" ind1=" " ind2=" ">
    <subfield code="a">Ozkan, Bulent</subfield>
    <subfield code="u">Katip Celebi Univ, Fac Med, Dept Biostat, Izmir, Turkey</subfield>
  </datafield>
  <datafield tag="700" ind1=" " ind2=" ">
    <subfield code="a">Soysal, Yasemin</subfield>
    <subfield code="u">Dokuz Eylul Univ, Inst Hlth Sci, Dept Mol Med, Izmir, Turkey</subfield>
  </datafield>
  <datafield tag="700" ind1=" " ind2=" ">
    <subfield code="a">Said, Harun Muayad</subfield>
    <subfield code="u">Dokuz Eylul Univ, Inst Hlth Sci, Dept Mol Med, Izmir, Turkey</subfield>
  </datafield>
  <datafield tag="909" ind1="C" ind2="4">
    <subfield code="p">TURKISH JOURNAL OF BIOCHEMISTRY-TURK BIYOKIMYA DERGISI</subfield>
    <subfield code="v">46</subfield>
    <subfield code="n">4</subfield>
    <subfield code="c">445-454</subfield>
  </datafield>
  <datafield tag="980" ind1=" " ind2=" ">
    <subfield code="a">user-tubitak-destekli-proje-yayinlari</subfield>
  </datafield>
  <datafield tag="540" ind1=" " ind2=" ">
    <subfield code="a">Creative Commons Attribution</subfield>
    <subfield code="u">http://www.opendefinition.org/licenses/cc-by</subfield>
  </datafield>
  <datafield tag="024" ind1=" " ind2=" ">
    <subfield code="a">10.1515/tjb-2020-0507</subfield>
    <subfield code="2">doi</subfield>
  </datafield>
  <datafield tag="245" ind1=" " ind2=" ">
    <subfield code="a">Evaluation of potential tumor markers that may predict neoadjuvant treatment efficiency in rectal cancer</subfield>
  </datafield>
  <datafield tag="100" ind1=" " ind2=" ">
    <subfield code="a">Arslan, Fatma Demet</subfield>
    <subfield code="u">Univ Hlth Sci, Tepecik Training &amp; Res Hosp, Dept Med Biochem, Gaziler St,468, TR-35180 Izmir, Turkey</subfield>
  </datafield>
  <datafield tag="909" ind1="C" ind2="O">
    <subfield code="o">oai:aperta.ulakbim.gov.tr:231278</subfield>
    <subfield code="p">user-tubitak-destekli-proje-yayinlari</subfield>
  </datafield>
  <datafield tag="650" ind1="1" ind2="7">
    <subfield code="2">opendefinition.org</subfield>
    <subfield code="a">cc-by</subfield>
  </datafield>
  <datafield tag="260" ind1=" " ind2=" ">
    <subfield code="c">2021-01-01</subfield>
  </datafield>
  <datafield tag="856" ind1="4" ind2=" ">
    <subfield code="u">https://aperta.ulakbim.gov.trrecord/231278/files/bib-ac5d5eef-9483-4386-9e51-b9bf50806926.txt</subfield>
    <subfield code="z">md5:746770f9982495d04496be2a63a0026f</subfield>
    <subfield code="s">322</subfield>
  </datafield>
  <datafield tag="542" ind1=" " ind2=" ">
    <subfield code="l">open</subfield>
  </datafield>
  <controlfield tag="005">20221007080538.0</controlfield>
  <controlfield tag="001">231278</controlfield>
  <datafield tag="980" ind1=" " ind2=" ">
    <subfield code="a">publication</subfield>
    <subfield code="b">article</subfield>
  </datafield>
  <datafield tag="520" ind1=" " ind2=" ">
    <subfield code="a">Objectives: The recurrence of rectal cancer or its resistance to neoadjuvant treatment develops due to the adaptation to hypoxia, apoptosis or autophagy. Survivin, one of the inhibitors of apoptosis; Beclin 1, which is a positive regulator in the autophagy pathway; and hypoxia-inducible factor-1 alpha (HIF-1 alpha) and carbonic anhydrase-9 (CA9), which are associated with tumor tissue hypoxia, may be related to resistance to treatment. Our aim was to evaluate the potential tumor markers that may help to monitor the response to neoadjuvant treatment in locally advanced rectal cancer (RC).</subfield>
  </datafield>
</record>
25
5
görüntülenme
indirilme
Görüntülenme 25
İndirme 5
Veri hacmi 1.6 kB
Tekil görüntülenme 23
Tekil indirme 5

Alıntı yap